Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

It can also contribute to the risk of high blood pressure, heart disease, stroke, and other serious conditions. One way to treat sleep apnea is with a CPAP machine—a mask and hose that is worn over ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

ResMed stock tumbled Friday after organic sales growth slowed somewhat in the second fiscal quarter. But one analyst remained upbeat on the "mega trends" driving the CPAP maker.Please watch the video ...

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...

Auto-titrating continuous positive airway pressure, or AutoCPAP therapy, is useful for the treatment of obstructive sleep apnea. It is delivered via a face mask and tubing that attaches to a device ...

My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...

January is almost over. For most of us, that means the making and breaking of New Year’s resolutions will (thankfully) be done with for another year.

In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...